Statistics

	Views
DO CHRONIC MYELOID LEUKEMIA PATIENTS WITH LATE "WARNING" RESPONSES BENEFIT FROM SWITCHING THERAPY TO A SECOND GENERATION TYROSINE KINASE INHIBITOR?	71

Select a period of time:

	Views
DO CHRONIC MYELOID LEUKEMIA PATIENTS WITH LATE "WARNING" RESPONSES BENEFIT FROM SWITCHING THERAPY TO A SECOND GENERATION TYROSINE KINASE INHIBITOR?	5

RUNA digital repository